|
HY-119464-10mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-100mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-25mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-5mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-50mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-117444-10mg
|
MedChemexpress LLC
|
ONO-9780307 [CAS 856691-44-6]
|
|
Cancer-programmed cell death
|
|
|
HY-117444-100mg
|
MedChemexpress LLC
|
ONO-9780307 [CAS 856691-44-6]
|
|
Cancer-programmed cell death
|
|
|
HY-117444-25mg
|
MedChemexpress LLC
|
ONO-9780307 [CAS 856691-44-6]
|
|
Cancer-programmed cell death
|
|
|
HY-117444-5mg
|
MedChemexpress LLC
|
ONO-9780307 [CAS 856691-44-6]
|
|
Cancer-programmed cell death
|
|
|
HY-117444-50mg
|
MedChemexpress LLC
|
ONO-9780307 [CAS 856691-44-6]
|
|
Cancer-programmed cell death
|
|
|
HY-W110929-100mg
|
MedChemexpress LLC
|
Patent Blue V [CAS 129-17-9]
|
|
Cancer-programmed cell death
|
|
|
HY-W110929-500mg
|
MedChemexpress LLC
|
Patent Blue V [CAS 129-17-9]
|
|
Cancer-programmed cell death
|
|
|
HY-A0261-10mg
|
MedChemexpress LLC
|
Pentagastrin [CAS 5534-95-2]
|
|
Cancer-programmed cell death
|
|
|
HY-A0261-100mg
|
MedChemexpress LLC
|
Pentagastrin [CAS 5534-95-2]
|
|
Cancer-programmed cell death
|
|
|
HY-A0261-25mg
|
MedChemexpress LLC
|
Pentagastrin [CAS 5534-95-2]
|
|
Cancer-programmed cell death
|
|
|
HY-A0261-5mg
|
MedChemexpress LLC
|
Pentagastrin [CAS 5534-95-2]
|
|
Cancer-programmed cell death
|
|
|
HY-A0261-50mg
|
MedChemexpress LLC
|
Pentagastrin [CAS 5534-95-2]
|
|
Cancer-programmed cell death
|
|
|
HY-A0261-1mL
|
MedChemexpress LLC
|
Pentagastrin [CAS 5534-95-2] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-B0144-10mg
|
MedChemexpress LLC
|
Pitavastatin (Calcium) [CAS 147526-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-B0144-100mg
|
MedChemexpress LLC
|
Pitavastatin (Calcium) [CAS 147526-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-B0144-5mg
|
MedChemexpress LLC
|
Pitavastatin (Calcium) [CAS 147526-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-B0144-50mg
|
MedChemexpress LLC
|
Pitavastatin (Calcium) [CAS 147526-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-B0144-1mL
|
MedChemexpress LLC
|
Pitavastatin (Calcium) [CAS 147526-32-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-B0144A-10mg
|
MedChemexpress LLC
|
Pitavastatin [CAS 147511-69-1]
|
|
Cancer-programmed cell death
|
|
|
HY-B0144A-5mg
|
MedChemexpress LLC
|
Pitavastatin [CAS 147511-69-1]
|
|
Cancer-programmed cell death
|
|
